John H Fetting MD
Associate Professor of Oncology, Associate Professor of Medicine, Assistant
Join to View Full Profile
10803 Falls RoadPavilion Iii Ste 1500Lutherville, MD 21093
Phone+1 410-583-2970
Fax+1 410-583-2980
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Fetting, MD is an oncologist in Lutherville, Maryland. He is currently licensed to practice medicine in Maryland. He is an Associate Professor of Oncology at Assistant.
Education & Training
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1977 - 1980
Johns Hopkins UniversityResidency, Internal Medicine, 1975 - 1977- Johns Hopkins University School of MedicineClass of 1975
Certifications & Licensure
MD State Medical License 1975 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- 4 citationsFeasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.Karen Lisa Smith, Hua-Ling Tsai, David Lim, Chenguang Wang, Raquel Nunes
JCO Oncology Practice. 2023-11-01 - 8 citationsOlaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.Elaine M Walsh, Neha Mangini, John Fetting, Deborah Armstrong, Isaac S Chan
Clinical Breast Cancer. 2022-06-01 - 25 citationsAssociation of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation.Karen Lisa Smith, Neha Verma, Amanda L Blackford, Jennifer Lehman, Kelly Westbrook
NPJ Breast Cancer. 2022-04-21
